This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Butyricimonas: NCBI 574697, [genus]

Back to details

| Butyricimonas| Butyricimonas Sakamoto et al. 2009 emend. Sakamoto et al. 2014

  1. Butyric Acid Production:

    • Butyricimonas bacteria are known for their ability to produce butyric acid, a short-chain fatty acid (SCFA). Butyric acid is considered beneficial for gut health, as it serves as an energy source for colonocytes (cells lining the colon) and may contribute to the maintenance of a healthy gut epithelium.
  2. Anti-Inflammatory Effects:

    • Butyric acid, produced by certain bacteria including Butyricimonas, has been associated with anti-inflammatory effects in the gut. It may help modulate immune responses and contribute to the maintenance of a balanced and tolerant gut environment.
  3. Gut Barrier Function:

    • Butyricimonas and other butyrate-producing bacteria have been linked to the improvement of gut barrier function. A healthy gut barrier is crucial for preventing the translocation of harmful substances and pathogens from the gut lumen into the bloodstream.
  4. Metabolism of Dietary Fiber:

    • Butyricimonas, like many other bacteria in the gut, is involved in the fermentation of dietary fibers. This process produces SCFAs, including butyric acid, and helps break down complex carbohydrates that are not digested in the upper gastrointestinal tract.
  5. Associations with Diet:

    • The abundance and activity of Butyricimonas in the gut can be influenced by dietary factors. Diets rich in fiber and plant-based foods provide substrates for the fermentation processes carried out by Butyricimonas and other gut bacteria.
  6. Gut Microbiota Composition:

    • Changes in the composition of the gut microbiota, including the abundance of Butyricimonas, have been associated with various health conditions. Dysbiosis (imbalance in the gut microbiota) is implicated in conditions such as inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and metabolic disorders.

Other Sources for more information:

Legend

Butyricimonas impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.461287319660186770.6973161101341248OdoribacterParent Taxa
0.37874129414558410.635513961315155AlistipesParent Taxa
0.37120848894119260.6245495676994324VescimonasParent Taxa
0.35408049821853640.5996881127357483ParaprevotellaParent Taxa
0.344183862209320070.5835115313529968CoprobacterParent Taxa
0.33917218446731570.5960425734519958LeyellaParent Taxa
0.31677219271659850.5846265554428101CloacibacteriumParent Taxa
0.31652399897575380.5737296938896179IntestinimonasParent Taxa
0.31081235408782960.5729089379310608SimiaoaParent Taxa
0.31067910790443420.5980503559112549MetamycoplasmaParent Taxa
0.29397514462471010.5504269599914551PusillibacterParent Taxa
0.267990976572036740.5315976738929749BilophilaParent Taxa
0.26432272791862490.527259111404419LachnospiraParent Taxa
0.25502064824104310.5165392756462097PrevotellaParent Taxa
0.25111529231071470.5037444829940796PseudocitrobacterParent Taxa

Other bacteria of the same rank impacting Butyricimonas

R2SlopeTax NameParent Chart
0.44352379441261290.6659955382347107OdoribacterParent Taxa
0.376996636390686040.6393643617630005CoprobacterParent Taxa
0.36596432328224180.6180392503738403ParaprevotellaParent Taxa
0.35899940133094790.6004334688186646VescimonasParent Taxa
0.35408556461334230.586024284362793AlistipesParent Taxa
0.33013790845870970.5770810842514038LeyellaParent Taxa
0.325300812721252440.6581801772117615OxalobacterParent Taxa
0.32218250632286070.6186341643333435BarnesiellaParent Taxa
0.321173459291458130.5781764984130859IntestinimonasParent Taxa
0.301509946584701540.5618871450424194PusillibacterParent Taxa
0.299070179462432860.5720911026000977OscillibacterParent Taxa
0.29266959428787230.5408925414085388SimiaoaParent Taxa
0.28971886634826660.6103243827819824DesulfovibrioParent Taxa
0.288564175367355350.5627425909042358PhascolarctobacteriumParent Taxa
0.285654067993164060.5640962719917297WujiaParent Taxa
0.277085006237030030.5614814758300781SegatellaParent Taxa
0.26964169740676880.5932219624519348MageeibacillusParent Taxa
0.25988528132438660.5873945355415344ChordicoccusParent Taxa
0.255676418542861940.5816295742988586CloacibacillusParent Taxa
0.254541635513305660.5159472227096558LawsonibacterParent Taxa
0.253283619880676270.5066396594047546LachnospiraParent Taxa
0.253045856952667240.5035557746887207PrevotellaParent Taxa
0.250685572624206540.5003246068954468BilophilaParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]